Stay updated on BAT2206 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the BAT2206 vs Stelara in Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision was updated to v3.6.6, replacing the previous v3.6.5. This is a minor metadata update and does not change the study content or visible information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe Zhejiang University hospital location name was standardized to 'Second Affiliated Hospital, Zhejiang University, School of Medicine' (replacing the previous form). The revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page displays an updated revision tag: v3.6.4, replacing the previous v3.6.3. This reflects a small update to the page version without altering study content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page shows an updated revision label, moving from v3.6.2 to v3.6.3, indicating a minor software update to the ClinicalTrials.gov interface. This change does not alter study data or visible content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page rather than a change to study details.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study), along with minor formatting changes to the Intervention/Treatment label and an updated Revision: v3.6.0.SummaryDifference0.5%

Stay in the know with updates to BAT2206 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.